NRD
EGRX

Nebula Research & Development’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Nebula Research & Development’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,473
Closed -$181K – 906
2023
Q3 		$181K Buy
11,473
+1,117
+11% +$17.6K 0.1% 416
2023
Q2 		$201K Buy
+10,356
New +$201K 0.15% 272